ISBN:
9780443433399
Copyright:
2027
Page Count:
1344
Imprint:
Elsevier
List Price:
$50.99
Elsevier’s 2027 Intravenous Medications - Elsevier eBook on VitalSource, 43rd Edition
by Shelly Rainforth Collins, PharmD, BCGP
Elsevier eBook on VitalSource
ISBN:
9780443433399
Copyright:
2027
Page Count:
1344
Imprint:
Elsevier
List Price:
$50.99
$50.99
Or $0.00 with a valid access code
Not Yet Available
Coming Soon!
Expected availability date: 06-18-2026
**Selected for 2026 Doody's Core Titles as an Essential Purchase in Medical/Surgical**
Find the essential information you need to safely administer more than 400 intravenous drugs! The newest edition of a reference trusted for more than 50 years, Elsevier’s 2027 Intravenous Medications is a concise, quick-access guide to complete, accurate drug information. New to this edition are 10-20 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.
Find the essential information you need to safely administer more than 400 intravenous drugs! The newest edition of a reference trusted for more than 50 years, Elsevier’s 2027 Intravenous Medications is a concise, quick-access guide to complete, accurate drug information. New to this edition are 10-20 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.
-
- Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference
- Convenient, A-to-Z format organizes all drug monographs by generic name, allowing you to find any drug in seconds
- Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more
- 50-year history of impeccable accuracy reinforces the importance of safe IV drug administration
- Proven, clinically-optimized page layout keeps all dosage information for each drug on either a single page or a two-page spread to prevent hand contamination by having to turn a page
- Highlighted Black Box Warnings make it easy to locate information on medications with serious safety risks
- Blue-screened text calls attention to other circumstances not covered by Black Box Warnings
- Dosage and dilution charts within monographs provide quick summaries of essential clinical information
- Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients
- Additional drug monographs are provided on the companion Evolve website
-
- NEW! Drug monographs for approximately 10-20 newly approved drugs by the FDA include the most current information
- NEW! Updates with new interactions, precautions, alerts, drug uses, patient teaching instructions, and more are included throughout the guide to reflect changes and prevent medication dispensing errors
- NEW! QR codes for additional drug monographs enable quick access at the point of care
-
General Dilution Charts
How to Use This Book
Evolve Website Information
Format and Content of Intravenous Medications
Key to Abbreviations
Important IV Therapy Facts
Resources
IV Drugs
Alphabetical Drug Monographs
Appendix A: Recommendations for the Safe Use and Handling of Cytotoxic Drugs
Appendix B: FDA Pregnancy Categories
Appendix C: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE)
Appendix D: Information for Patients Receiving Immunosuppressive Agents
Appendix E: Recently Approved Drugs
Index -
-
Ways of Reading
- The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
- This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
- No information about nonvisual reading is available
-
Conformance
- No information is available
-
Navigation
- Table of contents to all chapters of the text via links
- Page list to go to pages from the print source version
-
Rich Content
- No information is available
-
Hazards
- No information is available
-
Product Content
- No information is available
-
Legal Considerations
- No information is available
-
Additional Accessibility Information
- Content is enhanced with ARIA roles to optimize organization and facilitate navigation
- Page breaks included from the original print source
- For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
- E-publication includes basic navigation (usually less detailed than TOC-based navigation)
- Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
- All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
- The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.
-
Ways of Reading
$50.99
Or $0.00 with a valid access code
Not Yet Available
Coming Soon!
Expected availability date: 06-18-2026
as described in our 